Athira Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Athira Pharma Inc
TickerATHA
CIK #0001620463
CUSIP04746L104
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address4000 Mason Road, Suite 300 Box 352141, Seattle, WA 981952141
Source [EDGAR]
CIK Filing 2011 - 2025
[0001620463] 10-K
[0001620463] 10-Q
[0001620463] 3
[0001620463] 4
[0001620463] 5
[0001620463] 8-K
[0001620463] D
[0001620463] SC 13D
[0001620463] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Oliveira Steven Michael Athira Pharma Inc [2025-04-16] 0.0
BML Investment Partners LP Athira Pharma Inc [2024-11-07] 5.8
Baker Bros Advisors LP Athira Pharma Inc [2024-02-14] 8.3
Kayne Richard A Athira Pharma Inc [2023-04-20] 5.3
BlackRock Inc Athira Pharma Inc [2022-02-04] 6.6
Franklin Resources Inc Athira Pharma Inc [2022-02-03] 5.6
Kawas LEEN Athira Pharma Inc [2021-02-16] 5.2
Perceptive Advisors LLC Athira Pharma Inc [2021-02-08] 0.8
Venrock Healthcare Capital Partners II LP Athira Pharma Inc [2020-11-16] 5.1
RTW Investments LP Athira Pharma Inc [2020-09-28] 8.66
Viking Global Investors LP Athira Pharma Inc [2020-09-28] 6.9
Form 3/4/5 Filer 2011 - 2025
Athira Pharma, Inc.
Litton Mark James
San Martin Javier
Worthington Mark
Renninger Robert
Church Kevin
Edelman Joseph
Kosacz Barbara
Johnson James A
Pickering Grant
Fluke John M Jr
Panzara Michael A.
Romano Kelly A
Gengos Andrew
Lenington Rachel
Moebius Hans
Perceptive Advisors LLC
Perceptive Life Sciences Master Fund Ltd
Mileson Glenna
Yamada Tadataka
Kawas LEEN
RTW Investments LP
Wong Roderick
Form 13F Holdings
Firm Period DFND Voting Shares
Perceptive Advisors LLC [2025-06-30] SOLE 5,402,964 5,402,964
BML Capital Management LLC [2025-06-30] SOLE 0 3,230,667
Vanguard Group Inc [2025-06-30] SOLE 0 1,524,656
Propel Bio Management LLC [2025-06-30] DFND 0 1,492,792
Simplify Asset Management Inc [2025-06-30] SOLE 1,492,792 1,492,792
Tang Capital Management LLC [2025-06-30] OTR 0 600,000
Bank of America Corp /DE/ [2025-06-30] DFND 415,000 416,203
Acadian Asset Management LLC [2025-06-30] DFND 405,481 405,481
BlackRock, Inc. [2025-06-30] SOLE 376,454 376,454
Pathstone Holdings, LLC [2025-06-30] SOLE 0 372,196
Geode Capital Management LLC [2025-06-30] DFND 305,964 305,964
Renaissance Technologies LLC [2025-06-30] SOLE 241,000 241,000
Citadel Advisors LLC [2025-06-30] DFND 234,228 234,228
UBS Group AG [2025-06-30] DFND 202,543 203,475
Qube Research & Technologies Ltd [2025-06-30] SOLE 192,684 192,684
Two Sigma Advisers LP [2025-06-30] SOLE 143,100 154,200
Laird Norton Wetherby Trust Company, LLC [2025-06-30] SOLE 127,309 127,309
State Street Corp [2025-06-30] DFND 107,381 107,381
Susquehanna International Group LLP [2025-06-30] OTR 80,524 80,524
Osaic Holdings Inc [2025-06-30] DFND 0 63,500
Northern Trust Corp [2025-06-30] DFND 53,609 53,609
Clarius Group, LLC [2025-06-30] SOLE 53,551 53,551
XTX Topco Ltd [2025-06-30] DFND 52,986 52,986
Integrity Financial Corp /WA [2025-06-30] SOLE 0 52,902
[2025-06-30] SOLE 0 35,765
Brighton Jones LLC [2025-06-30] SOLE 0 32,200
Royal Bank of Canada [2025-06-30] DFND 27,156 27,156
Virtu Financial LLC [2025-06-30] DFND 24,742 24,742
Simon Quick Advisors LLC [2025-06-30] SOLE 0 20,538
Journey Strategic Wealth LLC [2025-06-30] SOLE 0 20,538
Prev | Page 7 | Next
Terms | Privacy | Guide
tony@aum13f.com